Vanguard Group Inc ownership in MYGN / Myriad Genetics, Inc.

Myriad Genetics, Inc.

US ˙ NasdaqGS ˙ US62855J1043

Security	MYGN / Myriad Genetics, Inc.
Institution	Vanguard Group Inc
Latest Disclosed Ownership	0 shares
Ownership	0.00%

2026-03-27 - Vanguard Group Inc has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 0 shares of Myriad Genetics, Inc. (US:MYGN). This represents 0.0 percent ownership of the company. In their previous filing dated 2025-10-31 , Vanguard Group Inc had reported owning 7,882,515 shares, indicating a decrease of -100.00 percent.

Institutional Ownership: 13D/G Filings

This table shows a history of the 13D/G filings made by the investor and/or investor group. Note that the share values in this table are not directly comparable to any numbers shown in the 13F table (if any).

File Date	Effective Date	Form	Prev Shares	Latest Shares	ΔShares (Percent)	Ownership (Percent)	ΔOwnership (Percent)
2026-03-27	2026-03-27	13G/A	7,882,515	0	-100.00	0.00	-100.00
2025-10-31	2025-10-31	13G/A	9,257,493	7,882,515	-14.85	8.47	-15.64
2025-07-29	2025-07-29	13G/A	9,954,233	9,257,493	-7.00	10.04	-9.71
2024-02-13	2024-02-13	13G/A	9,311,761	9,954,233	6.90	11.12	-3.22
2023-02-09	2023-02-09	13G/A	9,149,521	9,311,761	1.77	11.49	0.26
2022-02-10	2022-02-10	13G/A	8,296,864	9,149,521	10.28	11.46	3.90
2021-02-10	2021-02-10	13G/A	8,320,574	8,296,864	-0.28	11.03	-1.34
2020-02-12	2020-02-12	13G/A	9,192,715	8,320,574	-9.49	11.18	-9.03
2019-02-11	2019-02-11	13G/A	7,224,302	9,192,715	27.25	12.29	17.83
2018-01-10	2018-01-10	13G/A	5,353,743	7,224,302	34.94	10.43	33.38
2017-02-10	2017-02-10	13G/A	4,853,649	5,353,743	10.30	7.82	12.52
2016-02-10	2016-02-10	13G/A		4,853,649		6.95
2015-02-11	2015-02-11	13G/A		4,752,636		6.51
2014-02-11	2014-02-11	13G/A		4,885,391		6.53
2013-02-12	2013-02-12	13G		4,434,538		5.44

Important Note: One of the primary uses of the 13D/G filings is to evaluate the ability of a firm to control a company (ie, the "beneficial ownership"). To that end, firms are required to report not just direct holdings in companies, but indirect holdings that they control. For investment firms, these indirect holdings can include shares in funds they manage, advisory accounts, and in the case of activist campaigns, pledged votes. Therefore, share counts listed in 13D/G filings can differ significantly than share counts listed in 13F filings.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel Premium Registration Required .

Disclosed Equity Positions (from 13F/NPORT Filings)

File Date	Effective Date	Form	Security	Class	ID	Reported Shares	ΔShares	ΔShares (%)	Reported Value (x1000)	ΔValue (%)	Alloc (%)
2026-01-29	2025-12-31	13F	MYRIAD GENETICS	COM	62855J104	8,225,371	342,856	4.35	50,586	-11.24	0.0007
2025-11-07	2025-09-30	13F	MYRIAD GENETICS	COM	62855J104	7,882,515	-1,374,978	-14.85	56,991	15.93	0.0009
2025-08-11	2025-06-30	13F	MYRIAD GENETICS	COM	62855J104	9,257,493	-1,410,262	-13.22	49,157	-48.05	0.0008
2025-05-09	2025-03-31	13F	MYRIAD GENETICS	COM	62855J104	10,667,755	76,712	0.72	94,623	-34.83	0.0017
2025-02-11	2024-12-31	13F	MYRIAD GENETICS	COM	62855J104	10,591,043	279,379	2.71	145,203	-48.59	0.0025
2024-11-13	2024-09-30	13F	MYRIAD GENETICS	COM	62855J104	10,311,664	246,993	2.45	282,436	14.73	0.0051
2024-08-13	2024-06-30	13F	MYRIAD GENETICS	COM	62855J104	10,064,671	28,963	0.29	246,182	15.06	0.0047
2024-05-10	2024-03-31	13F	MYRIAD GENETICS	COM	62855J104	10,035,708	81,475	0.82	213,961	12.30	0.0042
2024-03-11	2023-12-31	13F/A-1	MYRIAD GENETICS	COM	62855J104	9,954,233	789,496	8.61	190,524	29.61	0.0042
2024-02-14	2023-12-31	13F	MYRIAD GENETICS	COM	62855J104	9,954,233	789,496		190,524		0.0036
2023-12-18	2023-09-30	13F/A-1	MYRIAD GENETICS	COM	62855J104	9,164,737	12,390	0.14	147,002	-30.71	0.0036
2023-11-14	2023-09-30	13F	MYRIAD GENETICS	COM	62855J104	9,164,737	12,390		147,002		0.0007
2023-08-14	2023-06-30	13F	MYRIAD GENETICS	COM	62855J104	9,152,347	-146,067	-1.57	212,151	-1.78	0.0050
2023-07-14	2023-03-31	13F/A-1	MYRIAD GENETICS	COM	62855J104	9,298,414	-13,347	-0.14	216,002	59.87	0.0055
2023-05-15	2023-03-31	13F	MYRIAD GENETICS	COM	62855J104	9,298,414	-13,347		216,002		0.0011
2023-02-10	2022-12-31	13F	MYRIAD GENETICS	COM	62855J104	9,311,761	183,377	2.01	135,114	-22.42	0.0037
2022-11-14	2022-09-30	13F	MYRIAD GENETICS	COM	62855J104	9,128,384	121,704	1.35	174,170	6.43	0.0051
2022-08-12	2022-06-30	13F	MYRIAD GENETICS	COM	62855J104	9,006,680	30,087	0.34	163,651	-27.66	0.0046
2022-05-13	2022-03-31	13F	MYRIAD GENETICS	COM	62855J104	8,976,593	-172,928	-1.89	226,211	-10.42	0.0054
2022-02-14	2021-12-31	13F	MYRIAD GENETICS	COM	62855J104	9,149,521	116,324	1.29	252,527	-13.42	0.0057
2021-11-12	2021-09-30	13F	MYRIAD GENETICS	COM	62855J104	9,033,197	82,377	0.92	291,681	6.56	0.0072
2021-08-13	2021-06-30	13F	MYRIAD GENETICS	COM	62855J104	8,950,820	326,155	3.78	273,716	4.22	0.0068
2021-05-14	2021-03-31	13F	MYRIAD GENETICS	COM	62855J104	8,624,665	327,801	3.95	262,621	60.07	0.0071
2021-02-12	2020-12-31	13F	MYRIAD GENETICS	COM	62855J104	8,296,864	298,846	3.74	164,070	57.31	0.0048
2020-11-16	2020-09-30	13F	MYRIAD GENETICS	COM	62855J104	7,998,018	-248,394	-3.01	104,295	11.53	0.0035
2020-08-14	2020-06-30	13F	MYRIAD GENETICS	COM	62855J104	8,246,412	-119,035	-1.42	93,514	-21.88	0.0033
2020-05-15	2020-03-31	13F	MYRIAD GENETICS	COM	62855J104	8,365,447	44,873	0.54	119,710	-47.16	0.0051
2020-02-14	2019-12-31	13F	MYRIAD GENETICS	COM	62855J104	8,320,574	-329,677	-3.81	226,569	-8.51	0.0077
2019-11-14	2019-09-30	13F	MYRIAD GENETICS	COM	62855J104	8,650,251	326,482	3.92	247,655	7.10	0.0092
2019-08-14	2019-06-30	13F	MYRIAD GENETICS	COM	62855J104	8,323,769	-214,508	-2.51	231,234	-18.43	0.0087
2019-05-15	2019-03-31	13F	MYRIAD GENETICS	COM	62855J104	8,538,277	-654,438	-7.12	283,471	6.08	0.0111
2019-02-14	2018-12-31	13F	MYRIAD GENETICS	COM	62855J104	9,192,715	535,782	6.19	267,233	-32.89	0.0120
2018-12-13	2018-09-30	13F/A-2	MYRIAD GENETICS	COM	62855J104	8,656,933	365,697	4.41	398,219	28.52	0.0156
2018-11-23	2018-09-30	13F/A-1	MYRIAD GENETICS	COM	62855J104	8,656,933	0		398,219		0.0156
2018-11-14	2018-09-30	13F	MYRIAD GENETICS	COM	62855J104	8,656,933	365,697		398,219
2018-08-14	2018-06-30	13F	MYRIAD GENETICS	COM	62855J104	8,291,236	516,568	6.64	309,843	34.87	0.0130
2018-05-15	2018-03-31	13F	MYRIAD GENETICS	COM	62855J104	7,774,668	550,366	7.62	229,742	-7.41	0.0100
2018-02-14	2017-12-31	13F	MYRIAD GENETICS	COM	62855J104	7,224,302	896,790	14.17	248,118	8.38	0.0108
2017-11-14	2017-09-30	13F	MYRIAD GENETICS	COM	62855J104	6,327,512	19,774	0.31	228,930	40.45	0.0107
2017-08-24	2017-06-30	13F/A-1	MYRIAD GENETICS	COM	62855J104	6,307,738	56,708	0.91	162,992	35.80	0.0080
2017-08-11	2017-06-30	13F	MYRIAD GENETICS	COM	62855J104	6,307,738	56,708		162,992
2017-05-12	2017-03-31	13F	MYRIAD GENETICS	COM	62855J104	6,251,030	897,287	16.76	120,020	34.48	0.0062
2017-02-14	2016-12-31	13F	MYRIAD GENETICS	COM	62855J104	5,353,743	158,531	3.05	89,248	-16.53	0.0050
2016-11-14	2016-09-30	13F	MYRIAD GENETICS	COM	62855J104	5,195,212	-1,454	-0.03	106,918	-32.76	0.0063
2016-08-10	2016-06-30	13F	MYRIAD GENETICS	COM	62855J104	5,196,666	121,681	2.40	159,018	-16.29	0.0099
2016-05-13	2016-03-31	13F	MYRIAD GENETICS	COM	62855J104	5,074,985	221,336	4.56	189,956	-9.32	0.0123
2016-02-08	2015-12-31	13F	MYRIAD GENETICS	COM	62855J104	4,853,649	173,406	3.71	209,484	19.42	0.0141
2015-11-12	2015-09-30	13F/A-1	MYRIAD GENETICS	COM	62855J104	4,680,243	-7,432	-0.16	175,415	10.09	0.0074
2015-11-12	2015-09-30	13F/A-1	MYRIAD GENETICS	COM	62855J104	4,680,243	-7,432		175,415		0.0074
2015-08-13	2015-06-30	13F	MYRIAD GENETICS	COM	62855J104	4,687,675	-60,354	-1.27	159,335	-5.20	0.0108
2015-05-15	2015-03-31	13F/A-1	MYRIAD GENETICS	COM	62855J104	4,748,029	-4,607	-0.10	168,080	3.83	0.0114
2015-05-14	2015-03-31	13F	MYRIAD GENETICS	COM	62855J104	4,748,029			168,080
2015-02-12	2014-12-31	13F	MYRIAD GENETICS	COM	62855J104	4,752,636	-45,831	-0.96	161,875	-12.54	0.0117
2014-11-12	2014-09-30	13F	MYRIAD GENETICS	COM	62855J104	4,798,467	-252,196	-4.99	185,077	-5.85	0.0144
2014-08-11	2014-06-30	13F	MYRIAD GENETICS	COM	62855J104	5,050,663	180,073	3.70	196,572	18.04	0.0155
2014-05-13	2014-03-31	13F	MYRIAD GENETICS	COM	62855J104	4,870,590	-14,801	-0.30	166,526	62.47	0.0140
2014-02-12	2013-12-31	13F	MYRIAD GENETICS	COM	62855J104	4,885,391	45,402	0.94	102,495	-9.89	0.0090
2013-11-07	2013-09-30	13F	MYRIAD GENETICS	COM	62855J104	4,839,989	439,892	10.00	113,740	-3.80	0.0111
2013-08-13	2013-06-30	13F	MYRIAD GENETICS	COM	62855J104	4,400,097	4,400,097		118,230		0.0124

Legend

Shares: The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value: The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price: The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class: This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred

Allocation (%): The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation: The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%): The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis: The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss: This is the market value of the position as of the effective date minus the cost basis.